A natural brain peptide that acts as the master 'on switch' for your reproductive hormone system.
Fertility, restoring menstrual cycles, and certain hormone-axis problems.
Strong evidence exists only for specific diagnoses — not for general hormone or libido boosting in healthy people.
What it is
Kisspeptin is the upstream master switch for your reproductive hormone system. Your hypothalamus produces it naturally, and it's what triggers the cascade that eventually results in your body producing estrogen, testosterone, and progesterone. Without adequate kisspeptin signaling, the whole reproductive axis goes quiet — which is exactly what happens in conditions like hypothalamic amenorrhea, where periods stop due to physiological stress. The strongest human evidence comes from research at Imperial College London, where kisspeptin has been studied extensively for restoring hormonal function in specific diagnoses, and as a gentler alternative to hCG for triggering egg release in IVF cycles. One important nuance: giving kisspeptin continuously rather than in pulses can paradoxically suppress the very system you're trying to support — because the receptor gets overloaded and stops responding. Protocol matters significantly with this one.
Potential benefits
Reproductive Hormone Stimulation — Best Evidence
Robustly stimulates LH, FSH, and sex hormones via GnRH. Phase 2 RCT in hypothalamic amenorrhea showed restored hormonal pulses and ovulatory function. Well-replicated.
IVF Trigger Alternative
Established as viable alternative to hCG for final egg maturation. Lower ovarian hyperstimulation syndrome (OHSS) risk in high-risk patients — clinically meaningful finding.
Libido & Sexual Function
Activates brain regions associated with sexual arousal. Human infusion studies show increased response to sexual stimuli. Not established as practical libido treatment outside clinical setting.
Testosterone Optimization (Men)
In hypogonadotropic hypogonadism — hypothalamic/pituitary dysfunction — can restore LH pulsatility and testosterone. Requires proper diagnosis.
Risks and contraindications
Side Effects (from clinical trials)
- Headache · Flushing
- Mild nausea
- Injection site reactions
- Hormonal fluctuation — expected with LH/sex hormone stimulation
Theoretical Risks
- GnRH axis desensitization with continuous (non-pulsatile) use — suppression paradox
- Unintended ovarian stimulation in women outside IVF context
- Interaction with HRT, OCP, testosterone therapy, fertility meds
Contraindications / cautions
- Hormone-sensitive cancers (breast, ovarian, prostate, uterine)
- Pregnancy · Under 18 (prepubertal)
- GnRH agonist therapy (endometriosis, prostate cancer) — direct antagonism
- PCOS (LH/FSH ratio concern) · Active fertility treatment (caution)
Research reality
Kisspeptin's role in regulating reproduction is among the most well-characterized areas in modern neuroendocrinology. The animal research is extensive and has been independently replicated many times.
Phase 1 and 2 trials have been completed, primarily by the Imperial College London group, with positive results for hypothalamic amenorrhea and IVF triggering published in peer-reviewed journals. Phase 3 trials, which would confirm findings at larger scale, haven't been completed yet.
Long-term safety data doesn't exist beyond the trial duration. The evidence is strong for specific diagnosed conditions — the important distinction is that this strength doesn't automatically extend to using kisspeptin for general hormone optimization in people who don't have a diagnosed axis disorder.
One of the strongest scientific foundations in this guide for its specific indications. But strong evidence ≠ evidence for general hormone optimization in healthy people — that gap is significant. If a diagnosed hormone-axis condition is in play, this becomes a serious clinical conversation. For general wellness goals, the evidence base does not exist in the same way.